Clinical trials
Scabies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Unknown status | 6 |
| Not yet recruiting | 5 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London School of Hygiene and Tropical Medicine | 4 |
| Medicines Development for Global Health | 3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Combined Military Hospital Abbottabad | 2 |
| Infectopharm Arzneimittel GmbH | 2 |
| Murdoch Childrens Research Institute | 2 |
| ParaPRO LLC | 2 |
| University of Oxford | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| B.P. Koirala Institute of Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scabies | 50 |
| Elephantiasis, Filarial | 5 |
| Impetigo | 4 |
| Neglected Diseases | 4 |
| Pruritus | 4 |
| Pyoderma | 4 |
| Strongyloidiasis | 3 |
| Yaws | 3 |
| Communicable Diseases | 2 |
| Onchocerciasis | 2 |
Trials
Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.